Published Date: 09 Mar 2023
Recent studies have shown poor outcomes in infants and children with postnatal development.
Read Full NewsA lung cancer trial was stopped early due to a high rate of fatal adverse events with the addition of thoracic radiotherapy to standard maintenance immunotherapy.
An FDA approval, striking CAR T data, and a field that can't agree on what to do next. Experts weigh in on the most contentious question in myeloma.
1.
Study finds 1 in 12 patients labeled as having 'benign' results actually had high-risk prostate cancer
2.
Older Adults With Advanced Cancer Prioritize Quality of Life
3.
Higher levels of HIF2α found to slow down aggressive childhood cancer
4.
Immunotherapy and targeted radiation shrink liver tumors, enabling surgery
5.
Top Options Are Discovered Through Direct Comparison of 25 Migraine Drugs.
1.
Exploring the Role of Fecal Leukocytes in Intestinal Health
2.
Unraveling the Mysteries of Burkitt Lymphoma: A New Hope for Treatment
3.
Iron Chelation Therapy: Preventing Long-Term Treatment Toxicities
4.
How to Manage Dic with the Right Treatment Approach
5.
Emerging Trends in Oncology for Modern Medicine
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
2.
Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
3.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion
4.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
5.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation